Back to grid

Longevity Β· Study

THE FIRST HUMAN TEST

The Diary of a CEO with Steven Bartlett Β· 17/09/2026 Β· added by men35 desk

THE FIRST HUMAN TEST

Cellular reprogramming has moved from mouse experiments into early human clinical testing. Here is what that milestone actually means. π—žπ—˜π—¬ π—•π—˜π—‘π—˜π—™π—œπ—§π—¦ Explains the first human testing of ER-100 Shows why the optic nerve is being targeted Clarifies what Phase 1 means Separates safety testing from age reversal 𝗙π—₯𝗒𝗠 π— π—œπ—–π—˜ 𝗧𝗒 𝗛𝗨𝗠𝗔𝗑𝗦 The most important development in this field may not be a headline about β€œreverse aging.” It is the fact that an experimental epigenetic reprogramming therapy has reached human clinical testing. ER-100 is being investigated in people with glaucoma or non-arteritic anterior ischemic optic neuropathy, conditions involving the optic nerve. ClinicalTrials.gov lists the study as a recruiting Phase 1 trial. π—ͺ𝗛𝗬 π—§π—›π—˜ π—˜π—¬π—˜? The optic nerve provides a relatively focused target for testing whether reprogramming can restore function in damaged or aging tissue. The approach builds on earlier mouse research showing that OSK reprogramming restored youthful molecular patterns and improved vision-related outcomes. π—£π—›π—”π—¦π—˜ 𝟭 π—œπ—¦ 𝗔 π—¦π—”π—™π—˜π—§π—¬ π—§π—˜π—¦π—§ This is crucial. A Phase 1 trial does not establish that ER-100 reverses aging. The first questions are whether the treatment can be given safely and what dose is appropriate. Later trials would need to demonstrate whether it actually improves clinically meaningful outcomes. π—ͺ𝗛𝗬 π—§π—›π—œπ—¦ π— π—”π—§π—§π—˜π—₯𝗦 If controlled cellular reprogramming proves safe and effective in humans, the implications could extend beyond one eye disorder. But that is a future possibilityβ€”not an established medical fact. π— π—˜π—‘πŸ―πŸ± π—§π—”π—žπ—˜π—”π—ͺ𝗔𝗬 The milestone is simple: Age-reversal biology has entered human testing. The resultsβ€”not the headlinesβ€”will determine what comes next. π—§π—›π—˜ 𝗕𝗒𝗧𝗧𝗒𝗠 π—Ÿπ—œπ—‘π—˜ ER-100 is an experimental therapy, not a consumer anti-aging treatment. For now, watch the clinical evidence.

#ER-100#clinical trial#David Sinclair#cellular reprogramming#epigenetic therapy#glaucoma#optic nerve#longevity science#aging research#biological aging#healthspan#regenerative medicine#human trials#age reversal#men over 35
Open source

For informational purposes only. This is not medical advice β€” consult a doctor before changing medication, supplements or training.